| Literature DB >> 804420 |
R O Brady, P G Pentchev, A G Gal.
Abstract
Enzyme replacement appears to offer much promise as specific therapeutic procedures for patients with Fabry's disease and Gaucher's disease. However, enzyme replacement in patients with Tay-Sachs disease and other heritable metabolic disorders where the central nervous system is affected will require first the development of effective methods for the delivery of exogenous enzymes to the brain; such methods are not yet available.Entities:
Mesh：
Substances：
Year: 1975 PMID： 804420
Source DB: PubMed Journal: Fed Proc ISSN： 0014-9446